AbbVie & Amgen: Safe Dividend Stocks for Recession Fears | 2026 - News and Statistics

NodeGuardian · 2026-04-04T18:37:21+00:00

In a volatile market, investors are turning to stable healthcare stocks like AbbVie and Amgen. AbbVie is seen as a safe investment due to its strong treatment portfolio, while Amgen offers stability despite patent challenges, appealing to risk-averse investors.

NodeGuardian

2026-04-04 18:37:21

Abstract generation in progress

Amidst growing recession fears and a volatile market, investors are seeking stability, leading to a focus on healthcare sector stocks like AbbVie and Amgen. AbbVie, a pharmaceutical company with strong portfolios in immunology, oncology, and neuroscience, is considered a safe bet due to its critical treatments and status as a Dividend King. Amgen, despite recent patent expirations, maintains business stability with a broad portfolio and promising pipeline, making both companies attractive for risk-averse investors.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes